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Background: The analysis of urinary proteome might reveal biomarkers of clinical value. However, current methods
of urine preparation for down-stream proteomic analysis are complicated, time-consuming, and/or expensive. This
study aims to develop a robust, simple, inexpensive and readily accessible urine preparation method to facilitate
clinical proteomic workflow.
Result: Syringe-push membrane absorption (SPMA) was successfully developed by a combination of 5-ml medical
syringe and protein-absorbable membrane. Comparing three membranes i.e., nitrocellulose, polyvinylidene difluoride
(PVDF) and Whatman no.1, nitrocellulose combined with SPMA (nitrocellulose-SPMA) provided the greatest quality of
proteome profile as demonstrated by 2-DE. The quality of the proteome profile and the performance of nitrocellulose-
SPMA were systematically compared with three current methods of urine preparation (i.e., ultrafiltration, dialysis/
lyophilization and precipitation). While different methods of urine preparation provided comparable proteome quality,
nitrocellulose-SPMA had better working performance due to acceptable recovery yield, less workload, short working
time, high accessibility and low unit cost. In addition, protein absorbed on nitrocellulose harvested from the SPMA
procedure could be stored as a dried membrane at room temperature for at least 1-month without protein degradation
or modification.
Conclusions: SPMA is a simple rapid method of preparing urine for downstream proteomic analysis. Because of it is
highly accessible and has long storage duration, this technique holds potential benefit for large-scale multi-center
research and future development of clinical investigation based upon urinary proteomic analysis.
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Urine is an ideal source for clinical proteomic analysis
due to non-invasive nature of sample collection [1, 2]. In
addition, urine serves as a protein/peptide reservoir repre-
senting alterations in renal diseases [3, 4], non-renal local-
ized conditions [5, 6] and systemic illnesses [7, 8]. Thus,
the urinary proteome is a gateway to identify non-invasive
biomarkers of clinical value. However, urine contains a
relatively low amount of proteins, and is contaminated
with a large amount of waste products (i.e., organic and* Correspondence: schuti.rama@gmail.com
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creativecommons.org/publicdomain/zero/1.0/non-organic molecules) which affect down-stream prote-
omic analysis [1, 2]. Therefore, good processing of urine
samples is crucial for non-invasive biomarker discovery
using the proteomic approach.
Commonly used methods of urine preparation for
proteomic analysis include ultrafiltration [6, 9], dialysis
with subsequent lyophilization [9, 10] and precipitation
by organic solvents [9]. Those techniques provide a high
quality urinary proteome profile. Nevertheless, some tech-
niques are complicated, laborious and/or time-consuming,
while others require specialized equipment and/or high-
cost consumable supplies. A new method of urine prepar-
ation that is uncomplicated, robust, inexpensive and readily
accessible would facilitate large-scale multi-center analysisAccess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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lysis in the future. This study therefore aimed to develop a
simple rapid and reproducible method of urine preparation
for clinical proteomics. Two-dimensional gel electrophor-
esis (2-DE), a mainstay approach of proteomics [11], was
applied to evaluate the quality of proteome profile. The
developed technique was systematically compared with the
current methods of urine preparation in several aspects.
The effect of storage duration on proteome stability
was also investigated to highlight the usefulness of this
technique in future large-scale research.
Results and discussion
Establishment of SPMA
The rationale of SPMA development was to devise a sim-
ple method of urine preparation that can be performed
anywhere (even at the patient’s bedside in the primary
hospitals) and is suitable for large-scale multi-center
analysis, while preserving the best quality of urinary
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Fig. 1 Silver Blue G-250 staining [12] showed deep blue staining of absorbed
(a). Absorbed proteins were eluted by 2-D lysis buffer and measured by the B
were subsequently analyzed by 2-DE (50 μg/gel) with silver blue G-250 staininthis conception, a novel technique was developed by
combined use of a 5-ml medical syringe regularly used
in clinical practice with membranes commonly used in
clinical laboratory. The medical syringe was used as a
pressure generator to push urine pass through the protein-
absorbable membrane placed inside. Urinary proteins were
absorbed onto the membrane surface and could be eluted
later for proteomic analysis. Therefore, the “syringe-push”
and “membrane absorption” were two core components of
this development (Additional file 1: Figure S1).
In order to select the most suitable membrane to com-
bine with SPMA, three commonly used membranes avail-
able in clinical laboratories, namely nitrocellulose, PVDF
and Whatman no.1, were tested and compared for protein
adsorption capability in the SPMA procedure. Silver blue
CBG-250 staining [12] was used to visualize the absorbed
protein on each membrane. Figure 1a showed that nitro-
cellulose and PVDF, but not Whatman no.1, had deep
blue staining after urine absorption as compared to faint
blue staining after deionized (dI) water absorption (blank1 2 3 4 
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proteins on nitrocellulose and PVDF, but not Whatman no.1 membranes
radford protein assay for recovery yield and inter-CV (b). Eluted proteins
g (c). All experiments were performed in triplicate
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teins on nitrocellulose had been removed, whereas a
significant amount of proteins on PVDF had still been
retained. Note that incomplete elution of PVDF may
affect recovery yield and reproducibility of protein iso-
lation. This qualitative data supported the potential usage
of nitrocellulose (more preferable) and PVDF (less prefer-
able) in the SPMA technique. Next, urine protein isolates
were quantitatively measured for recovery yield. Figure 1b
showed that nitrocellulose and PVDF provided a compar-
able level of protein recovery yield (41.8 ± 2.7 % vs. 39.7 ±
7.0 %), whereas Whatman no.1 had very low yield (4.5 ±
0.6 %), consistent to previous qualitative result. The re-
producibility of protein recovery yield of nitrocellulose
(intra-CV of 6.4 %) was greater than PVDF and Whatman
no.1 (intra-CV of 17.7 % and 13.3 %, respectively).
To evaluate compatibility of SPMA with down-stream
proteomic analysis, urine proteins derived from three types
of membrane were further analyzed by 2-DE (50 μg each
gel). Figure 1c showed urinary proteome of nitrocellulose,
PVDF and Whatman no.1, separated by 2-DE [11], stained
with silver blue [12]. The samples from nitrocellulose
provided more acidic proteins (pI range of 3–4) and had
better quality of proteome profile than that of PVDF and
Whatman no.1. For quantitative analysis, protein spot
numbers were counted by ImageMaster 2D Platinum
software. The results showed that nitrocellulose, PVDF
and Whatman no.1 had 197 ± 15, 185 ± 16 and 163 ± 7
protein spots, respectively. According to recovery yield,
reproducibility and quality of proteome profile, nitro-
cellulose was superior to PVDF and Whatman no.1, and
was chosen for use with SPMA (nitrocellulose-SPMA) for
subsequent evaluation.
Systematic comparison of nitrocellulose-SPMA, ultrafiltration,
dialysis/lyophilization and 75 % methanol precipitation
Figure 2 showed urinary proteome profile of nitrocellulose-
SPMA, compared to three current methods of urine
preparation, including ultrafiltration, dialysis/lyophilizationUltrafiltration Nitrocellulose-SPMA 
pI 3 10 pI 3 10 3
Fig. 2 Urinary proteome profile of isolated proteins from nitrocellulose-SPM
2-DE with silver blue G-250 staining (protein loading of 50 μg/gel). All exand 75 % methanol precipitation. Visually, all methods
provided comparable quality with some differences in
proteome pattern. The urinary proteome profile of
nitrocellulose-SPMA was nearly identical to 75 % metha-
nol precipitation, which is a preferred method of urine
preparation for gel-based proteomics [9]. Quantitative
analysis of protein spot numbers did not reveal significant
differences between nitrocellulose-SPMA, ultrafiltration,
dialysis/lyophilization, and 75 % methanol precipitation
(197 ± 15, 196 ± 15, 192 ± 17 and 199 ± 17 spots, respect-
ively) (p = 0.64) (Table 1). These results suggested that
proteome coverage of urine protein isolated by nitrocellulose-
SPMA was comparable to the standard methods of
urine preparation. Nevertheless, some degree of variations
among protocols could be expected, since different
methods may possess different protein selectivity. To
highlight the variation in protein selectivity, Western
Blot analysis (Additional file 2: Supplementary materials
and methods) was performed to detect four common urin-
ary proteins, i.e., Tamm-Horsfall protein (THP), alpha-
1-microglobulin (A1M), immunoglobulin gamma heavy
chain (IgG HC), and immunoglobulin kappa chain (Ig
Kappa) in the isolated proteins derived from nitrocellulose,
PVDF and ultrafiltration (10 μg each lane) (Additional
file 3: Figure S2). Based on four common urinary proteins,
selectivity of nitrocellulose and ultrafiltration was nearly
comparable, whereas PVDF provided the result with high
degree of variation (which may be due to difference in
protein selectivity or incomplete protein elution). This re-
sult again confirmed that nitrocellulose was more suitable
than PVDF for SPMA technique.
Performance of nitrocellulose-SPMA, ultrafiltration,
dialysis/lyophilization, and 75 % methanol precipitation
were compared and presented in Table 1. According to
recovery yield, dialysis/lyophilization provided the highest re-
covery (62.1 ± 8.4 %) as compared to that of nitrocellulose-
SPMA (41.9 ± 2.6 %), ultrafiltration (42.9 ± 0.6 %), and
methanol precipitation (55.6 ± 7.0 %). This result was not
surprising because dialysis/lyophilization usually providesDialysis/lyophilization 75% methanol precipitation 














A, ultrafiltration, lyophilization, and 75 % methanol precipitation on
periments were performed in triplicate
Table 1 Systematic evaluation on performances of urine preparation methods
Nitrocellulose-SPMA Ultrafiltration Dialysis/lyophilization 75 % methanol precipitation
Spot number mean ± SD (inter-CV) 197 ± 15 (7.6 %) 196 ± 15 (7.6 %) 192 ± 17 (8.8 %) 199 ± 17 (8.4 %)
%Yield mean ± SD (inter-CV) 41.9 ± 2.6 (6.4 %) 42.9 ± 0.6 (1.5 %) 62.1 ± 8.4 (13.6 %) 55.6 ± 7.0 (12.6 %)
Need of specialized/high-cost instrument No No Yes (lyophilizer) Yes (superspeed centifuge)
Working time (min) 15 35 >1440 65
Step of procedure 3 3 3 5
Unit cost (US$/5-ml urine) 0.3 6.3 0.3 1.8
Abbreviation: inter-CV inter-assay coefficient of variation
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SPMA had lower recovery yield compared to dialysis/
lyophilization and 75 % methanol precipitation, the pro-
tein recovered was comparable to ultrafiltration which
is adequate for proteomic analysis. To evaluate the ac-
cessibility of urine preparation protocol, the need for
specialized/high cost instrumentation also needs to be
considered. Nitrocellulose-SPMA and ultrafiltration do not
need specialized/high cost instrument, whereas dialysis/
lyophilization and 75 % methanol precipitation required a
lyophilizer and superspeed centrifuge, respectively. This
would be advantageous in large-scale proteomic analysis
using urine specimens initially prepared from less ac-
cessible regions. In clinical investigation, fewer steps in
the protocol procedure and less working time decrease
workload. Of the four methods, only 75 % methanol precipi-
tation requires a 5-step of procedure, while nitrocellulose-
SPMA, ultrafiltration, dialysis/lyophilization had 3-step
procedures (detailed in Materials and Methods section).
Thus, 75 % methanol precipitation was more complicated
to perform than the others. In our experience, urine prep-
aration by precipitation techniques also requires careful
training to obtain a reliable and reproducible 2-DE result.
The approximate working times of nitrocellulose-SPMA,
ultrafiltration, dialysis/lyophilization and 75 % methanol
precipitation were shown in Table 1 (detailed in Materials
and Methods section). Clearly, nitrocellulose-SPMA had
the least working time as compared to the others. In
terms of unit cost, nitrocellulose-SPMA and dialysis/
lyophilization cost only 0.3 US$ per 5-ml urine prepar-
ation, whereas ultrafiltration (6.3 US$) and 75 % methanol
precipitation (1.8 US$) had higher cost. Taken all these
factors into account, nitrocellulose-SPMA had better
working performance and was also cost-effective as com-
pared to the other methods.
Storage duration of urine protein-absorbed nitrocellulose
membrane
To emphasize the usefulness of nitrocellulose-SPMA in
clinical proteomics and large-scale multi-center analysis,
storage duration of the dried protein-absorbed membrane
was investigated. Membrane containing adsorbed urinary
protein was prepared by nitrocellulose-SPMA and then airdried before elution at the desired time points. 2-DE was
chosen for this evaluation due to its high sensitivity to
protein degradation (which can be observed as vertical
smearing) and protein modification (which can be observed
as horizontal shifting) [11]. Figure 3 shows the 2-DE of
urinary proteins eluted from nitrocellulose-SPMA with dif-
ferent storage times under room temperature. Interestingly,
there were no difference in proteome profile among four
conditions including immediate elution, 1-day storage,
1-week storage and 1-month storage. Neither vertical smear
nor horizontal shift of protein spots was observed. This
result suggested that urinary protein absorbed to the
membrane may be kept for up to 1 month for analytical
purposes.
Potential applications of SPMA technique on large-scale
analysis and future development of clinical investigation
based upon urinary proteomic technologies
Urinary proteomics is the promising tool for biomarker
discovery of clinical value, particularly when performed
in a large-scale fashion. However, a limitation for large-
scale analysis is sample preparation (due to complicated
protocol, lack of equipment and/or inadequate funding,
especially in developing countries) and sample shipment
as cooled/frozen specimens. The newly develop SPMA
overcomes those limitations. The simplicity and accessi-
bility of SPMA can overcome bottlenecks due to difficult
sample preparation and handling in urinary proteomics.
Because of its robustness and low unit cost, SPMA is
therefore compatible with handling a large number of
urine specimens in a clinical setting. Long storage stabil-
ity of the dried urine protein-absorbed membrane (up to
1-month at room temperature) allows specimen collec-
tion from rural areas for large-scale research and/or clin-
ical investigation based upon urinary proteomic analysis
(Additional file 4: Figure S3). This also overcomes prob-
lems due to shipping of urine specimens (i.e., protein
stability, apparatus for packaging and shipping expense
due to liquid storage and weight). All of these highlight
the cost-effectiveness of nitrocellulose-SPMA in clinical
proteomics.
Recently, a PVDF-based urine protein absorption using
vacuum suction filter bottle system was described by
Immediate elution 
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Fig. 3 Storage duration of urinary proteins absorbed on the nitrocellulose membrane after SPMA procedure. After urine protein absorption, the
membrane was air dried and kept at room temperature until elution at 1-day, 1-week and 1-month. Immediate elution served as control condition.
2-DE was performed to assess protein degradation and/or modification after long storage. No change of urinary proteome was observed up
to 1-month
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scale prospective studies [13]. Reproducibility of urinary
protein isolation and protein stability after 18-day
storage at various temperatures (i.e., room temperature,
4 °C, −20 °C and −80 °C) were demonstrated using
SDS-PAGE analysis. Unfortunately, proteome coverage
and protein modification had not been evaluated due
to the limitation of SDS-PAGE analysis. By changing
PVDF to nitrocellulose, the same group of investigators
showed that urinary proteins derived from nitrocellulose
membrane absorption had the same degree of reprodu-
cibility and proteome coverage as those of acetone pre-
cipitation by LC-MS/MS analysis [14]. However, the
advantages of membrane absorption technique over the
other conventional methods (e.g., ultrafiltration or dialysis/
lyophilization) have remained unclear. Also, a rationale of
membrane selection (PVDF vs. nitrocellulose) has never
been described.
Our study has provided additional information to the
previous works. The evaluation was performed in a sys-
tematic manner. The compact design makes SPMA more
economical and more accessible than the vacuum suction
filter bottle system. Nitrocellulose was superior to PVDF
and Whatman no.1 in term of yield, reproducibility and
proteome quality of the isolated urinary proteins, making
the rationale of membrane selection for this procedure.
Importantly, nitrocellulose and PVDF are not replaceable
because of different proteome profile (Fig. 1c). For large-
scale urinary protein collection based on membrane
absorption techniques (either SPMA or vacuum suction
filter bottle system), making a right decision on membrane
selection is crucial. Advantages of SPMA over the con-
ventional methods including ultrafiltration, dialysis/
lyophilization and 75 % methanol precipitation were clearly
demonstrated in the aspects of working performance
and cost-effectiveness. One-month storage time of urineprotein-absorbed membrane at room temperature, with-
out protein degradation and/or modification, was an add-
itional benefit to this technique. By step-wise evaluation,
nitrocellulose-SPMA was highlighted as a method of
choice of urine preparation for clinical proteomic ana-
lysis, especially by the gel-based approach.
In conclusion, nitrocellulose-SPMA described here is a
robust, simple, inexpensive and readily accessible method
of urine preparation for clinical proteomics. Nitrocellulose-
SPMA is not only has benefits for research purposes,
but also for clinical investigations based upon proteomic




The international urine collection protocol created as a
result of joint consensus of European Kidney and Urine
Proteomics (EuroKUP) [15] and the Human Kidney
and Urine Proteome Project [16] (http://eurokup.org)
was followed. Mid-stream of 2nd morning urine from six
normal healthy individuals (three males; age of 34.3 ±
6.4 years and three females; age of 29.0 ± 4.3 years) were
collected with 1 mM sodium azide and kept at 4 °C. The
collected urine was pretreated by centrifugation at 1000 ×
g for 10 min to remove cells and debris. Pooled urine was
then generated from 100 ml urine per individual, stored
aliquots of 10 ml at −20 °C, and used throughout this
study. This study was approved by the Ethical Clearance
Committee on Human Right Related to Research involv-
ing Human Subjects, Faculty of Medicine Ramathibodi
Hospital, Mahidol University (Protocol ID 01-58-06).
Establishment of SPMA technique
A schematic diagram represented SPMA was showed in
Additional file 1: Figure S1. Three commonly available
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Inc., Hercules, CA), polyvinylidene difluoride (PVDF) and
Whatman no.1 filter membrane (Whatman no.1) were
selected for this study. The membrane was cut into a
disc-shaped membrane with an approximate diameter of
1.2 cm. The disc-shaped membrane was carefully installed
at the bottom of a 5 ml medical syringe (Terumo Medical
Corp., Somerset, NJ). Complete sealing of the syringe out-
let by the disc-shaped membrane is necessary to maximize
the yield of protein absorption. Optionally, Whatman
ashless grade 40 filter paper (a diameter of 1.2 cm) was
inserted before installation of the membrane to prevent
leakage. For urinary protein absorption, 5-ml urine was
filled into a membrane-filled syringe and then pushed
through the membrane using the plunger at an approxi-
mate flow rate of 1 ml/min. Positive pressure generated by
pushing the syringe is crucial to absorb urinary proteins
onto the membrane. To eliminate salt and waste product
contamination, 5-ml dI water was push through the
protein-absorbed membrane at the similar flow rate. The
protein-absorbed membrane was harvested and incu-
bated with 2-D lysis buffer (7 M urea, 2 M thiourea,
4 % CHAPS (3-[(3-Cholamidopropyl) dimethylammonio]-
1-propanesulfonate), 2 % (v/v) IPG pH 3–10, 120 mM
dithiothreital (DTT) and 40 mM Tris (1,3-Propanediol,
2-amino-2-(hydroxymethyl)) in an Eppendorf tube for
5-min to elute urinary proteins. For long-term storage,
the harvested membrane was air dried and kept at room
temperature in a clean plastic bag until use. Protein con-
centration was measured using Bradford protein assay.Ultrafiltration
To obtain the best proteome coverage by ultrafiltration,
3-kDa MWCO microsep™ advanced centrifugal filter
(Pall Life Science, Ann Arbor, MI) was used. Ultrafiltration
was performed as described previously [6, 9]. Briefly, 5-ml
urine was spun at 12,000 × g using an ultrafiltration col-
umn at 4 °C until approximately 1/30 of initial volume
remained. Ten volumes of 90 mM Tris–HCl, pH 7.4 was
used as a changing buffer in order to get rid of salt con-
tamination. The concentrated urinary protein was har-
vested and kept at −20 °C until use. Protein concentration
was measured using the Bradford protein assay.Dialysis/lyophilization
Urine preparation by dialysis and lyophilization was
performed as described previously [9, 10]. Briefly, 5-ml
urine was filled in a dialysis bag with a molecular weight
cut off (MWCO) of 3–5 kDa and then dialyzed against dI
water at 4 °C overnight with a total dilution factor of
16,000. The dialyzed urine was then lyophilized using a
freeze dryer for about 6-h or until completely dry. The ly-
ophilized urinary protein was then resuspended in 2-Dlysis buffer and kept −20 °C until used. Protein concentra-
tion was measured using the Bradford protein assay.
75 % methanol precipitation
Various organic solvents may be used to precipitate urin-
ary proteins but no single solvent is perfect [9]. However,
previous study showed that 75 % methanol precipitation
provided a good quality proteome profile, high recovery
yield and was easy to handle, compared to other solvents
[9]. Therefore, 75 % methanol precipitation was selected
as a representative precipitation technique and was per-
formed as described previously [9]. Briefly, methanol and
the pooled urine were pre-cooled at 4 °C for 30 min before
adding methanol into the urine to the final concentration
of 75 % v/v. The solution was mixed and incubated at 4 °C
for 10 min to allow protein precipitation. The precipitant
was isolated by superspeed centrifugation at 12,000 g for
5 min. The supernatant was carefully discarded and the
pellet was air-dry under room temperature for 15 min and
then resuspended using 2-D lysis buffer. Protein concen-
tration was measured using the Bradford protein assay.
2-DE and staining
Fifty micrograms of extracted protein was mixed with
rehydration buffer (7 M urea, 2 M thiourea, 4 % CHAPS,
0.5 % (v/v) IPG buffer pH 3–10, 60 mM DTT and
40 mM Tris) and rehydrated into a 7-cm IPG strip
(pH 3–10) for 10–15 h at room temperature. The first
dimension separation or isoelectric focusing (IEF) was
performed by the Ettan IPGphor III IEF System (GE
Healthcare, Little Chalfont, UK) at 20 °C using a step-
wise voltage increase to reach 9000 Vh. The focused IPG
strip was equilibrated with an equilibration buffer (6 M
urea, 130 mM DTT, 112 mM Tris–HCl pH 8.8, 4 %
SDS, 30 % glycerol and 0.002 % bromophenol blue) for
15 min, followed by a second equilibration for 15 min in
the same solution containing 135 mM iodoacetamide in-
stead of DTT. The equilibrated strip was transferred to
the top of a 12.5 % polyacrylamide gel and then second
dimensional separation was performed using SE260 mini-
Vertical Electrophoresis Unit at 150 V for approximately
2 h. Protein spots were visualized by silver blue CBG-250
staining [12]. The stained gel was scanned by Ettan DIGE
Imager (GE Healthcare). Numbers of protein spot were
detected using ImageMaster 2D-Platinum software ver-
sion 6.0 (GE Healthcare).
Comparisons among urine preparation methods
Quality of proteome profile
Quality of proteome profile was judged by visualized
mapping of the pattern and resolution of protein spots
on 2-DE [11], and quantitatively evaluated by the numbers
of protein spots detected by ImageMaster 2D-Platinum
software. Data was presented as mean ± SD and inter-
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pendent experiments.
Recovery yield
Total protein amount of pooled urine and the isolated
protein (based on a total volume of 5-ml urine each) were
measured by the Bradford assay. Recovery yield was calcu-
lated as followed;
%Yield ¼ Total protein amount of the isolated protein mgð Þ  100
Total protein amount of the pooled urine mgð Þ
Where, [total protein amount of the isolated protein
(mg) = protein concentration of the eluate (mg/ml) × the
volume of the elute (ml)]. Data was presented as mean ±
SD and inter-CV of three independent experiments.
Steps in procedure and working time
Steps in each procedure and approximated working time
were estimated based upon the manipulation of 5-ml
urine as follows: 3 steps for SPMA (5-min for membrane
absorption, 5-min for washing, and 5-min for elution), 3
steps for ultrafiltration (15-min for protein concentration,
15-min for desalting and 5-min for harvesting), 3 steps for
dialysis/lyophilization (960-min for dialysis, 360-min or
more for lyophilization, 5-min for solubilization) and 5
steps for precipitation (30-min for pre-cooling, 10-min for
precipitation, 5-min for superspeed centrifugation, 15-min
for air drying, and 5-min for solubilization).
Accessibility and unit cost
Accessibility of urine preparation method was evaluated
by the need of specialized/high cost instruments (defined
by cost greater than 12,500 US$). Based on this, two
methods, namely dialysis/lyophilization and precipitation
(which require a freeze dryer and a superspeed centrifuge,
respectively) were categorized as being low accessibility
techniques. Unit cost was approximated by the cost of
consumable materials used for 5-ml urine manipulation
(US$/5-ml urine).
Statistical analysis
Statistical analysis was performed with SPSS version 11.5
(SPSS, Inc., Chicago, IL). Data were analyzed by unpaired
t-test or ANOVA to determine the difference between
groups. All experiments were performed in triplicate and
presented as mean ± SD. P-value < 0.05 is considered as
statistical significance.
Additional files
Additional file 1: Figure S1. Schematic diagram representing the
SPMA procedure. A 5-ml medical syringe was prefilled with a disc-shape
protein absorbable membrane (A). Five-ml of urine was pushed through
the membrane using a plunger to enhance protein absorption (B and C).Urinary proteins were eluted from the harvested membrane using 2-D
lysis buffer and prepared for subsequent proteomic analysis (D). SPMA;
syringe-push membrane absorption.
Additional file 2: Supplementary materials and methods.
Additional file 3: Figure S2. Western blotting using specific antibodies
against 4 abundant urinary proteins, i.e., Tamm-Horsfall protein (THP),
immunoglobulin gamma heavy chain (IgG HC), alpha-1-microglobulin
(A1M) and immunoglobulin kappa chain (Ig Kappa) were performed to
evaluate protein selectivity of nitrocellulose and PVDF. Urinary protein
derived from ultrafiltration was served as the control condition. Equal
amount of 10 μg protein was loaded in each lane. The data shown was
representative of triplicate experiments.
Additional file 4: Figure S3. Proposed usefulness of nitrocellulose-SPMA
in large-scale multicenter proteome research and/or clinical investigation
based upon urinary proteomic analysis. A. Urine protein specimens are
prepared by nitrocellulose-SPMA at a primary hospital and sent as dried
membranes via mail to the central hospital and/or the research institute. B.
Proteins are eluted and submitted to proteomic analysis. C. For research
purposes, relevant pathogenic mechanisms and/or biomarkers of clinical
value can be identified by large-scale analysis. D. Later, when clinical
investigation based on proteomic technologies are complete, the results are
sent back to primary hospital for further patient care.
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